secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001628280-23-000737
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus appoints John A. Bartholdson to board as Class II director effective Jan 8, 2023
--------------------------------------------------------------------------------

- John A. Bartholdson, 52, co-founder and Partner at Juniper Investment Company, appointed to Bioventus board effective Jan 8, 2023.
- He will serve as Class II director until 2023 annual meeting or successor elected.
- Bartholdson receives annual cash retainer of $55,000 and initial RSU award valued at $152,000.
- He brings 25 years experience in private/public equity, currently chairs Theragenics board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023000737/0001628280-23-000737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023000737/bvs-20230108.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-000737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer